Kureha Kagaku Kogyo Kabushiki Kaisha

Fumio Hirose

Takayoshi Fujii

Chikao Yoshikumi

Yoshio Ohmura

Kenichi Matsunaga

Takao Ando

Masanori Ikuzawa

Minoru Ohhara

Toshihiko Wada

Saburo Ueno

Eiichi Takahashi

Yoshio Omura

Minoru Ohara

Yuji Maeda

Kenichi Saito

Tadaaki Kato

Hideyuki Yamato

Yasuhiko Kobayashi

Shigeto Ohtsuka

Disclosed is a pharmaceutical composition containing an aminobenzoic acid derivative as an active ingredient represented by the following general formula: ##STR1## wherein .sup.1 R donotes one member selected from the group consisting of the residual groups formed by removing OH at 1(alpha) or 1(beta) position from arabinose, glucose, galactose and mannose, or a pharmaceutically acceptable salt thereof.

Pharmaceutical compositions containing a derivative of para-aminobenzoic

Pharmaceutical composition containing a derivative of para-aminobenzoic

Disclosed herein is a method for inhibiting the formation of urinary calculus by the administration of 24,25-dihydroxycholecarciferol.

Method for inhibiting the formation of urinary calculus utilizing

Disclosed is nitrogen-containing polysaccharide substantially free of units having a molecular weight below about 5,000, said nitrogen-containing polysaccharide having been extracted from Coriolus versicolor (Fr.) Quel., substantially all polymer units having a molecular weight below about 5,000 having been removed therefrom, which exhibits antitumor and immunological activity.

Nitrogen-containing polysaccharide

Disclosed is a pharmaceutical composition containing p-aminobenzoic acid-N-D-xyloside or a pharmaceutically a acceptable salt thereof as an active ingredient.

Pharmaceutical composition containing para-amino-benzoic

Disclosed is a method for the treatment of hyperglycemia, hyperlipemia, inflammatory diseases, pains due to the accentuation of central nerve, pyrexia due to the accentuation of central nerve or tumor, which comprises administering to a patient suffering therefrom a pharmaceutically effective amount of p-aminobenzoic acid-N-L-rhamnoside or a pharmaceutically acceptable salt thereof.

Method for the treatment of tumors

Disclosed is a pharmaceutical composition containing an aminobenzoic acid derivative as an active ingredient represented by the following general formula: ##STR1## wherein .sup.1 R denotes one member selected from the group consisting of the residual groups formed by removing OH at 1(alpha) or 1(beta) position from arabinose, xylose, glucose, galactose, rhamnose and mannose, and .sup.2 R denotes hydrogen or methyl group, or a pharmaceutically acceptable salt thereof.

Pharmaceutical composition containing a derivative of orthoaminobenzoic

A method of restoring the immune response of a patient having a lowered immune response level is provided, in which the patient is given an effective amount of certain nitrogen-containing polysaccharides derived from Coriolus versicolor (Fr.) Quel, where the polymer units having a molecular weight of below about 5,000 have been removed therefrom.

P-aminobenzoic acid-N-L-rhamnoside pharmaceutical compositions for

Disclosed is a pharmaceutical composition containing p-aminobenzoic acid-N-L-rhamonoside or a pharmaceutically acceptable salt thereof as an active ingredient.

Pharmaceutical composition containing para-aminobenzoic

Method for the treatment of pains or pyrexia due to the accentuation of

Disclosed is a pharmaceutical composition containing an aminobenzoic acid derivative as an active ingredient represented by the following general formula: ##STR1## wherein .sup.1 R denotes one member selected from the group consisting of the residual groups formed by removing OH at 1(alpha) or 1(beta) position from arabinose, glucose, galactose and mannose, or a pharmaceutically acceptable salt thereof.

Growing community of inventors

Tokyo, Japan

Fumio Hirose